Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antecolic Versus Retrocolic Gastrojejunostomy Following Pancreaticoduodenectomy: a Prospective Randomised Study

NCT06914349 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT06914349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antecolic Versus Retrocolic Gastrojejunostomy Following Pancreaticoduodenectomy: a Prospective Randomised Study
Lead sponsor
University of Thessaly
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2025
Completion date
March 31, 2029
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas neoplasms, pancreatic cancer resectable